Literature DB >> 9809728

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

R A Patchell1, P A Tibbs, W F Regine, R J Dempsey, M Mohiuddin, R J Kryscio, W R Markesbery, K A Foon, B Young.   

Abstract

CONTEXT: For the treatment of a single metastasis to the brain, surgical resection combined with postoperative radiotherapy is more effective than treatment with radiotherapy alone. However, the efficacy of postoperative radiotherapy after complete surgical resection has not been established.
OBJECTIVE: To determine if postoperative radiotherapy resulted in improved neurologic control of disease and increased survival.
DESIGN: Multicenter, randomized, parallel group trial.
SETTING: University-affiliated cancer treatment facilities. PATIENTS: Ninety-five patients who had single metastases to the brain that were treated with complete surgical resections (as verified by postoperative magnetic resonance imaging) between September 1989 and November 1997 were entered into the study.
INTERVENTIONS: Patients were randomly assigned to treatment with postoperative whole-brain radiotherapy (radiotherapy group, 49 patients) or no further treatment (observation group, 46 patients) for the brain metastasis, with median follow-up of 48 weeks and 43 weeks, respectively. MAIN OUTCOME MEASURES: The primary end point was recurrence of tumor in the brain; secondary end points were length of survival, cause of death, and preservation of ability to function independently.
RESULTS: Recurrence of tumor anywhere in the brain was less frequent in the radiotherapy group than in the observation group (9 [18%] of 49 vs 32 [70%] of 46; P<.001). Postoperative radiotherapy prevented brain recurrence at the site of the original metastasis (5 [10%] of 49 vs 21 [46%] of 46; P<.001) and at other sites in the brain (7 [14%] of 49 vs 17 [37%] of 46; P<.01). Patients in the radiotherapy group were less likely to die of neurologic causes than patients in the observation group (6 [14%] of 43 who died vs 17 [44%] of 39; P=.003). There was no significant difference between the 2 groups in overall length of survival or the length of time that patients remained functionally independent.
CONCLUSIONS: Patients with cancer and single metastases to the brain who receive treatment with surgical resection and postoperative radiotherapy have fewer recurrences of cancer in the brain and are less likely to die of neurologic causes than similar patients treated with surgical resection alone.

Entities:  

Mesh:

Year:  1998        PMID: 9809728     DOI: 10.1001/jama.280.17.1485

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  449 in total

Review 1.  Radiotherapy for brain tumors.

Authors:  M P Mehta; W A Tomé; G H Olivera
Journal:  Curr Oncol Rep       Date:  2000-09       Impact factor: 5.075

Review 2.  Solitary cerebellar metastasis as a presentation for colon cancer: a case report and review of the literature.

Authors:  J DeWitt; H R Lippman; W Wassef
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

Review 3.  Neurosurgical management of metastases in the central nervous system.

Authors:  Elizabeth B Claus
Journal:  Nat Rev Clin Oncol       Date:  2011-12-06       Impact factor: 66.675

Review 4.  Management of brain metastasis: past lessons, modern management, and future considerations.

Authors:  Eugene Koay; Erik P Sulman
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

5.  Metastatic Disease of the Nervous System.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-11       Impact factor: 3.598

6.  Brain metastases: the need for a more tailored approach in non-small-cell lung cancer patients.

Authors:  P Martínez; E Felip
Journal:  Clin Transl Oncol       Date:  2012-01       Impact factor: 3.405

7.  [Radiotherapy of singular brain metastases].

Authors:  Stefanie Windischbauer; Felix Sedlmayer
Journal:  Wien Med Wochenschr       Date:  2010-02

Review 8.  Whole-brain radiation therapy in breast cancer patients with brain metastases.

Authors:  Cyrus Chargari; François Campana; Jean-Yves Pierga; Lionel Védrine; Damien Ricard; Sylvestre Le Moulec; Alain Fourquet; Youlia M Kirova
Journal:  Nat Rev Clin Oncol       Date:  2010-07-13       Impact factor: 66.675

9.  Nested Cohort Study to Identify Characteristics That Predict Near-Term Disablement From Lung Cancer Brain Metastases.

Authors:  Andrea L Cheville; Jeffrey R Basford; Ian Parney; Ping Yang; Felix E Diehn
Journal:  Arch Phys Med Rehabil       Date:  2016-09-22       Impact factor: 3.966

Review 10.  CNS complications of breast cancer: current and emerging treatment options.

Authors:  Evert C A Kaal; Charles J Vecht
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.